Dyadic International Share Price Today
(NASDAQ: DYAI)

Name: Dyadic International Share Price Today (NASDAQ: DYAI) - Dyadic International Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Dyadic International share price is $1.38 & ₹119.96 as on 15 Mar 2025, 2.30 'hrs' IST

$1.38

▲

-0.04

(-2.82%)

Market is closed - opens 7 PM, 17 Mar 2025

View live Dyadic International share price in Dollar and Rupees. Guide to invest in Dyadic International stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Dyadic International, along with analyst recommendations, forecasts, and comprehensive financials.

Dyadic International share price movements

Today's Low: $1.38
Today's High: $1.55
$1.38
0.0%
Downside
Day's Volatility :10.92%
Upside
10.92%
52 Weeks Low: $0.93
52 Weeks High: $2.67
$1.38
32.92%
Downside
52 Weeks Volatility :65.33%
Upside
48.31%

Dyadic International (DYAI) Returns

Period	Dyadic International Inc	Index (Russel 2000)
3 Months	-4.7%	0.0%
6 Months	15.45%	0.0%
1 Year	-5.33%	0.0%
3 Years	-59.08%	-8.9%

Dyadic International (DYAI) Key Statistics

in dollars & INR

Previous Close	$1.42
Open	$1.4
Today's High	$1.5491
Today's Low	$1.38
Market Capitalization	$33.6M
Today's Volume	$12.0K
52 Week High	$2.67
52 Week Low	$0.9257
Revenue TTM	$1.8M
Earnings Per Share (EPS)	$-0.27
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-127.38%

How to invest in Dyadic International Stock (DYAI) from India?

It is very easy for Indian residents to invest directly in Dyadic International from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Dyadic International stock in both Indian Rupees (INR) and US Dollars (USD). Search for Dyadic International or DYAI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Dyadic International or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Dyadic International shares which would translate to 0.630 fractional shares of Dyadic International as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Dyadic International, in just a few clicks!

Returns in Dyadic International (DYAI) for Indian investors in Rupees

The Dyadic International stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Dyadic International investment value today

Current value as on today

₹96,956

Returns

₹3,044

(-3.04%)

Returns from Dyadic International Stock

₹8,000 (-8%)

Dollar Returns

₹4,956 (+4.96%)

Indian investors sentiment towards Dyadic International (DYAI)

-7%

Period: Feb 12, 2025 to Mar 14, 2025. Change in 30 Days versus previous period

Search interest for Dyadic International Stock from India on INDmoney has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Dyadic International

Bandera Partners LLC
5.30%
Chapin Davis Inc
2.93%
Vanguard Group Inc
2.72%
BlackRock Inc
0.85%
Northeast Financial Consultants, Inc
0.84%
BB&T Corp.
0.84%

Analyst Recommendation on Dyadic International

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Dyadic International(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Dyadic International Stock (DYAI)

What analysts predicted

Upside of 334.78%

Target:

$6.00

Current:

$1.38

Insights on Dyadic International Stock (Ticker Symbol: DYAI)

Price Movement
In the last 6 months, DYAI stock has moved up by 14.5%
Increasing Revenue
Revenue is up for the last 3 quarters, 334.61K → 1.95M (in $), with an average increase of 46.8% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -2.04M → -203.46K (in $), with an average increase of 905.2% per quarter
DYAI vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.8% return, outperforming this stock by 69.4%
DYAI vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 59.3% return, outperforming this stock by 118.3%
Price to Sales
ForDYAI every $1 of sales, investors are willing to pay $22.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.7 for every $1 of sales.

DYAI Dyadic International Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$1.3M	↑ 70.81%
Net Income	$-5.7M	↑ 166.49%
Net Profit Margin	-439.36%	↓ 157.75%

	FY19	Y/Y Change
Revenue	$1.7M	↑ 29.77%
Net Income	$-8.3M	↑ 45.96%
Net Profit Margin	-494.21%	↓ 54.85%

	FY20	Y/Y Change
Revenue	$1.6M	↓ 4.71%
Net Income	$-9.3M	↑ 12.24%
Net Profit Margin	-582.13%	↓ 87.92%

	FY21	Y/Y Change
Revenue	$2.4M	↑ 50.06%
Net Income	$-12.9M	↑ 38.57%
Net Profit Margin	-537.54%	↑ 44.59%

	FY22	Y/Y Change
Revenue	$2.9M	↑ 21.9%
Net Income	$-9.4M	↓ 27.48%
Net Profit Margin	-319.79%	↑ 217.75%

	FY23	Y/Y Change
Revenue	$2.9M	↓ 1.07%
Net Income	$-6.8M	↓ 27.48%
Net Profit Margin	-234.42%	↑ 85.37%

	Q2 FY23	Q/Q Change
Revenue	$837.2K	↓ 14.41%
Net Income	$-2.2M	↓ 1664.58%
Net Profit Margin	-257.17%	↓ 271.24%

	Q3 FY23	Q/Q Change
Revenue	$397.1K	↓ 52.57%
Net Income	$-1.6M	↓ 25.02%
Net Profit Margin	-406.55%	↓ 149.38%

	Q4 FY23	Q/Q Change
Revenue	$686.5K	↑ 72.9%
Net Income	$-2.1M	↑ 28.34%
Net Profit Margin	-301.78%	↑ 104.77%

	Q1 FY24	Q/Q Change
Revenue	$334.6K	↓ 51.26%
Net Income	$-2.0M	↓ 3.0%
Net Profit Margin	-600.57%	↓ 298.79%

	Q2 FY24	Q/Q Change
Revenue	$385.9K	↑ 15.32%
Net Income	$-2.0M	↑ 1.77%
Net Profit Margin	-529.99%	↑ 70.58%

	Q3 FY24	Q/Q Change
Revenue	$2.0M	↑ 407.26%
Net Income	$-203.5K	↓ 90.05%
Net Profit Margin	-10.39%	↑ 519.6%

	FY18	Y/Y Change
Profit	$268.2K	↑ 242.83%

	FY19	Y/Y Change
Profit	$221.4K	↓ 17.45%

	FY20	Y/Y Change
Profit	$177.0K	↓ 20.05%

	FY21	Y/Y Change
Profit	$459.4K	↑ 159.56%

	FY22	Y/Y Change
Profit	$807.1K	↑ 75.69%

	FY23	Y/Y Change
Profit	$923.0K	↑ 14.35%

	Q2 FY23	Q/Q Change
Profit	$44.2K	↓ 82.39%

	Q3 FY23	Q/Q Change
Profit	$291.2K	↑ 558.58%

	Q4 FY23	Q/Q Change
Profit	$336.4K	↑ 15.53%

	Q1 FY24	Q/Q Change
Profit	$190.7K	↓ 43.33%

	Q2 FY24	Q/Q Change
Profit	$83.9K	↓ 55.97%

	Q3 FY24	Q/Q Change
Profit	$1.6M	↑ 1760.38%

	FY18	Y/Y Change
Operating Cash Flow	$-4.4M	↑ 69.1%
Investing Cash Flow	$3.3M	↓ 509.85%
Financing Cash Flow	$-2.3M	↓ 63.04%

	FY19	Y/Y Change
Operating Cash Flow	$-5.8M	↑ 31.21%
Investing Cash Flow	$7.7M	↑ 131.57%
Financing Cash Flow	$550.2K	↓ 123.93%

	FY20	Y/Y Change
Operating Cash Flow	$-6.6M	↑ 13.69%
Investing Cash Flow	$22.1M	↑ 187.02%
Financing Cash Flow	$255.5K	↓ 53.57%

	FY21	Y/Y Change
Operating Cash Flow	$-11.3M	↑ 71.53%
Investing Cash Flow	$5.2M	↓ 76.4%
Financing Cash Flow	$1.2M	↑ 381.49%

	FY22	Y/Y Change
Operating Cash Flow	$-8.1M	↓ 28.32%
Investing Cash Flow	$-2.4M	↓ 145.37%
Financing Cash Flow	$543.6K	↓ 55.81%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-1.7M	↓ 24.34%
Investing Cash Flow	$1.1M	↓ 59.49%
Financing Cash Flow	$0.0	-

Dyadic International Technicals Summary

Sell

Neutral

Buy

Dyadic International is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Dyadic International (DYAI) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Dyadic International Inc	-15.98%	15.45%	-5.33%	-59.08%	-57.1%
Regeneron Pharmaceuticals, Inc.	2.52%	-40.97%	-29.43%	0.39%	54.39%
Beone Medicines Ltd	14.0%	29.59%	49.75%	38.86%	81.84%
Vertex Pharmaceuticals Incorporated	10.97%	2.76%	23.36%	102.37%	151.75%
Alnylam Pharmaceuticals, Inc.	-9.1%	-10.59%	61.95%	52.07%	145.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Dyadic International Inc	NA	NA	0.0	-0.28	-1.27	-0.46	NA	0.2
Regeneron Pharmaceuticals, Inc.	17.98	17.98	1.01	42.83	0.16	0.07	0.0	273.57
Beone Medicines Ltd	NA	NA	NA	1.45	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.4	18.06	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.52	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Dyadic International Inc	Buy	$33.6M	-57.1%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$75.4B	54.39%	17.98	31.07%
Beone Medicines Ltd	NA	$28.1B	81.84%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$127.2B	151.75%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	145.93%	NA	-12.37%

About Dyadic International

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health. The company offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial to demonstrate the safety in humans of a protein produced using the C1 platform. It has also developed the Dapibus thermophilic, a filamentous fungal-based microbial protein production platform to enable the development and large-scale manufacture of cost-effective proteins, metabolites, and other biologic products for use in non-pharmaceutical applications, including food, nutrition, and wellness. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa's Rubic One Health; Joint Development Agreement with a Global Food Ingredient Company; and sub-license agreement with Abic Biological Laboratories Ltd., Alphazyme, LLC, and Abic Biological Laboratories Ltd. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Organization	Dyadic International
Employees	7
CEO	Mr. Mark A. Emalfarb
Industry	Biotechnology

Management People of Dyadic International

Name	Title
Mr. Mark A. Emalfarb	Founder, CEO, President & Director
Ms. Ping Wang Rawson CPA, M.B.A.	Chief Financial Officer
Mr. Joseph P. Hazelton	Chief Operating Officer
Mr. Doug Pace B.A.	Executive Vice President of Business Development
Ms. Ana Gómez Rodriguez	Secretary of the Board

Important FAQs about investing in DYAI Stock from India :

What is Dyadic International share price today?

Dyadic International share price today stands at $1.38, Open: $1.40 ; Previous Close: $1.42 ; High: $1.55 ; Low: $1.38 ; 52 Week High: $2.67 ; 52 Week Low: $0.93.

The stock opens at $1.40, after a previous close of $1.42. The stock reached a daily high of $1.55 and a low of $1.38, with a 52-week high of $2.67 and a 52-week low of $0.93.

Can Indians buy Dyadic International shares?

Yes, Indians can invest in the Dyadic International (DYAI) from India.

With INDmoney, you can buy Dyadic International at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Dyadic International at zero transaction cost.

How can I buy Dyadic International shares from India?

It is very easy to buy Dyadic International from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Dyadic International (DYAI) be purchased?

Yes, you can buy fractional shares of Dyadic International with INDmoney app.

What are the documents required to start investing in Dyadic International stocks?

To start investing in Dyadic International, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.